Europa are delighted to link with I3E and look forward to early September Serenity appraisal spud. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhrm Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Agreement with Boston Globe Media Group

Fri, 9th Oct 2015 07:00

RNS Number : 7432B
Phorm Corporation Limited
09 October 2015

9 October 2015


Phorm Corporation Limited

("Phorm" or the "Company")

Agreement with Boston Globe Media Group

Phorm (AIM: PHRM), an advertising-technology company, is pleased to announce, further to its interim results released on 30 September 2015, that Boston Globe Media Group ("Boston Globe"), a leading U.S. digital media group, is implementing the Company's targeted advertising technology on its digital properties.


Phorm's cutting-edge Machine-Learning Artificial Intelligence ("AI") technology makes it easier and more efficient for publishers (and other sellers of advertisements) to identify and target specific audiences and extend audience reach to ultimately achieve more successful advertising campaigns. The Company's proprietary technology also provides unrivaled insight into digital advertising supply and demand dynamics such that publishers can regain more control of their advertising inventory.


Recognising the potential value and benefits of Phorm's software platform, Boston Globe will implement Phorm' technology across its digital properties to seek and achieve increased advertising sales and performance as well as optimised inventory control.


Boston Globe, through its developing relationship with Phorm, will continue to seek to extend its circa 4 - 5 million unique visitors per month, increase its advertising revenues through new sources, and optimise the revenue potential of all third party partnerships that it is working with, including Phorm.


Commenting on Boston Globe's decision to implement Phorm's platform, Pete Doucette, VP of Consumer Sales & Marketing, said:


"We are always looking to increase our revenue and margin, and engage with new users across our various websites and media channels. Phorm's technology will enable us to identify users in a deeper and more meaningful manner during their consumer journey with us and other sites, with an overarching objective of increasing our potential share of advertising spend."


Phorm's CEO, Timothy Smith, added:


"We're most energised and excited to be working with such a nationally esteemed brand as the Boston Globe, which is innovating through the use of technology. We are looking forward to demonstrating the power of our technology software platform and contributing to Pete and his team's enhanced understanding of their audience, delivering users more efficiently and recruiting new users of Boston Globe's content."




For further information please contact: 

Phorm Corporation Limited
Timothy Smith (Chief Executive Officer) +44 (0)20 33976001


Mirabaud Securities LLP (Broker) +44 (0)20 7321 2508

Jason Woollard 

Peter Krens


Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris Matthew Chandler James Dance



About Phorm

Phorm is a global advertising-technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.


Phorm's industry leading technology enables its Internet Service Provider ("ISP") and other partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.


Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.


Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.


Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.


For more information, please visit:

This information is provided by RNS
The company news service from the London Stock Exchange
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.